LaFleur & Godfrey’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,235
Closed -$1.19M 63
2018
Q3
$1.19M Hold
6,235
0.29% 48
2018
Q2
$1.04M Buy
6,235
+430
+7% +$69K 0.26% 48
2018
Q1
$977K Buy
5,805
+65
+1% +$10.9K 0.25% 47
2017
Q4
$939K Sell
5,740
-13,175
-70% -$2.36M 0.23% 54
2017
Q3
$3.88M Sell
18,915
-1,465
-7% -$341K 1.02% 35
2017
Q2
$4.95M Sell
20,380
-410
-2% -$96.3K 1.3% 29
2017
Q1
$4.97M Sell
20,790
-2,995
-13% -$697K 1.34% 29
2016
Q4
$5M Sell
23,785
-9,440
-28% -$1.96M 1.4% 26
2016
Q3
$7.65M Buy
33,225
+28,875
+664% +$7.06M 2.21% 15
2016
Q2
$1M Buy
+4,350
New +$1M 0.3% 53

Other funds holding AGN

LaFleur & Godfrey's AGN Position: Q4 2018 in Review

LaFleur & Godfrey sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 6,235 shares — an estimated $1.19M sold.

LaFleur & Godfrey first reported a position in AGN in Q2 2016 and held it in 10 quarters. The position peaked at $7.65M in Q3 2016. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • LaFleur & Godfrey reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • LaFleur & Godfrey sold 6,235 Allergan plc shares in Q4 2018, an estimated $1.19M.
  • LaFleur & Godfrey first reported a position in Allergan plc in Q2 2016 and held it in 10 quarters.
  • LaFleur & Godfrey's Allergan plc position peaked at $7.65M in Q3 2016.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on LaFleur & Godfrey's 13F filing for Q4 2018, filed 12 Feb 2019.